https://www.selleckchem.com/pr....oducts/telotristat-e
To evaluate the performance of selected host immunological biomarkers in differentiating tuberculosis (T disease from latent TB infection (LTBI) in HIV uninfected and infected individuals enrolled in TB low-burden countries. Participants with TB disease (N=85) and LTBI (N=15 were recruited from prospective cohorts at hospitals in Norway and Denmark. Plasma concentrations of 54 host markers were assessed by Luminex multiplex immunoassays. Using receiver operator characteristic curves and general discrim
Curtir
Comentario
Compartilhar
